Clinical Trials Browser

Carcinoma, Endometrioid × Sarcoma × Clear all

Nasopharyngeal Carcinoma, Bile Duct Neoplasms, Carcinoma, Basal Cell, Adenocarcinoma, Bronchiolo-Alveolar, Adenocarcinoma, Mucinous, Carcinoma, Transitional Cell, Carcinosarcoma, Chordoma, Carcinoma, Adenoid Cystic, Fibroma, Gallbladder Neoplasms, Hemangiosarcoma, Mouth Neoplasms, Paget Disease, Extramammary, Paraganglioma, Paranasal Sinus Neoplasms, Parathyroid Neoplasms, Pheochromocytoma, Pseudomyxoma Peritonei, Somatostatinoma, Thyroid Neoplasms, Vulvar Neoplasms, Desmoid Tumors, Seminoma, Carcinoma, Acinar Cell, Adrenocortical Carcinoma, Carcinoma, Endometrioid, Cholangiocarcinoma, Cystadenocarcinoma, Mucinous, Cystadenocarcinoma, Serous, Carcinoma, Giant Cell, Neurofibrosarcoma, Gestational Trophoblastic Disease, Rare Diseases, Gastrointestinal Stromal Tumors, Perivascular Epithelioid Cell Neoplasms

NCT03660826 2026-06-02

Testing the Combination of Olaparib and Durvalumab, Cediranib and Durvalumab, Olaparib and Capivasertib, and Cediranib Alone in Recurrent or Refractory Endometrial Cancer Following the Earlier Phase of the Study That Tested Olaparib and Cediranib in Comparison to Cediranib Alone, and Olaparib Alone

Phase 2 Active not recruiting

288 enrolled 21 charts

Sarcoma

Carcinosarcoma, Carcinoma, Endometrioid

NCT04065269 2026-02-20

ATARI

Phase 2 Active not recruiting

174 enrolled

GynecologicSarcoma

Carcinosarcoma, Uterine Cervical Neoplasms, Endometrial Neoplasms, Carcinoma, Endometrioid

NCT04458597 2025-08-01

Stereotactic Pelvic Adjuvant Radiation Therapy in Cancers of the Uterus.

Phase NA Completed

23 enrolled

Sarcoma

Carcinosarcoma, Adenocarcinoma, Clear Cell, Carcinoma, Endometrioid, Cystadenocarcinoma, Serous

NCT00132704 2014-07-24

An Analysis of the Response of Human Tumor Microvascular Endothelium to Ionizing Radiation

Completed

149 enrolled

DermatologicGastrointestinalGynecologicSarcomaThoracic

Adenocarcinoma, Carcinoma, Squamous Cell, Uterine Cervical Neoplasms, Leiomyosarcoma, Liposarcoma, Melanoma, Ovarian Neoplasms, Sarcoma, Colorectal Neoplasms, Endometrial Neoplasms, Carcinoma, Endometrioid, Carcinoma, Ductal, Small Cell Lung Carcinoma

Clinical Trials

Nivolumab and Ipilimumab in Treating Patients With Rare Tumors

Testing the Combination of Olaparib and Durvalumab, Cediranib and Durvalumab, Olaparib and Capivasertib, and Cediranib Alone in Recurrent or Refractory Endometrial Cancer Following the Earlier Phase of the Study That Tested Olaparib and Cediranib in Comparison to Cediranib Alone, and Olaparib Alone

ATARI

Stereotactic Pelvic Adjuvant Radiation Therapy in Cancers of the Uterus.

An Analysis of the Response of Human Tumor Microvascular Endothelium to Ionizing Radiation